By 8:30 AM, most Americans know if it'll be a good day, recent survey shows
Icelandic Provisions, a yogurt brand, polled 5,000 Americans, 100 people from each of the 50 states, to get a better sense of what leads to good days. The brand partnered with Talker Research for its second annual "Bowl Half Full: A Report on Optimism, Nutrition & Wellness."
About half of Americans polled (46%) felt that having a ritual or routine that made the day feel special was what led to a good day. For many, that ritual starts in the morning.
"Nearly half rely on a consistent morning ritual like preparing a healthy breakfast, walking, or journaling to set an optimistic tone," Icelandic Provisions said in a press release.
Most people could predict whether or not their day would be positive by 8:30 a.m., the study found.
Other contributors that stood out for people's good days were:
This aligns with what research shows helps people feel their happiest and even live longer.
In a longevity study from 2012, most centenarians had positive attitudes, Dr. Nil Barzilai, one of the study's co-authors, told ABC News. Typically, they were viewed by others as easygoing, optimistic and extroverted.
And an 87-year-long Harvard study found that the happiest people practice social fitness, maintaining close relationships and improving them over time.
"Invest in relationships, invest in connections and invest in the things you find meaningful," Dr. Robert Waldinger, the director of the Harvard Study of Adult Development, said during an interview at the New York Times Well Festival.
"If you're doing more of that, you're more likely to be happy more of the time. You won't be happy all the time. But happiness is likely to find you more often."
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Washington Post
34 minutes ago
- Washington Post
US health officials crack down on kratom-related products after complaints from supplement industry
WASHINGTON — U.S. health officials are warning Americans about the risks of an opioid-related ingredient increasingly added to energy drinks, gummies and supplements sold at gas stations and convenience stores, recommending a nationwide ban. The chemical, known as 7- hydroxymitragynine , is a component of kratom , a plant native to Southeast Asia that has gained popularity in the U.S. as an unapproved treatment for pain, anxiety and drug dependence.
Los Angeles Times
35 minutes ago
- Los Angeles Times
California, other states sue Trump administration over bill defunding Planned Parenthood
California and a coalition of other liberal-led states sued the Trump administration Tuesday over a provision in the 'Big Beautiful Bill' that bars Planned Parenthood and other large nonprofit abortion providers from receiving Medicaid funding for a host of unrelated healthcare services. The measure has threatened clinics across the country that rely on federal funding to operate. California Atty. Gen. Rob Bonta, who is helping to lead the litigation, called it a 'cruel, backdoor abortion ban' that violates the law in multiple ways. The states' challenge comes one day after Planned Parenthood won a major victory in its own lawsuit over the measure in Boston, where a federal judge issued a preliminary injunction blocking the ban from taking effect against Planned Parenthood affiliates nationwide. Federal law already prohibits the use of federal Medicaid funding to pay for abortions, but the new 'defund provision' in the bill passed by Congressional Republicans earlier this month goes further. It also bars nonprofit abortion providers that generated $800,000 or more in annual Medicaid revenue in 2023 from receiving any such funding for the next year — including for services unrelated to abortion, such as annual checkups, cancer screenings, birth control and testing for sexually transmitted infections. Attorneys for the U.S. Department of Justice have argued that the measure 'stops federal subsidies for Big Abortion,' that Congress under the constitution is 'free to decline to provide taxpayer funds to entities that provide abortions,' and that Planned Parenthood's position should not hold sway over that of Congress. In announcing the states' lawsuit Monday, Bonta's office echoed Planned Parenthood officials in asserting that the provision specifically and illegally targets Planned Parenthood and its affiliate clinics — calling it 'a direct attack on the healthcare access of millions of low-income Americans, disproportionally affecting women, LGBTQ+ individuals, and communities of color.' Bonta's office said the measure threatened $300 million in federal funding for clinics in California, where Planned Parenthood is the largest abortion provider, and 'jeopardized the stability' of Planned Parenthood's 114 clinics across the state, which serve about 700,000 patients annually — many of whom use Medi-Cal, the state's version of Medicaid. During a virtual news conference Monday, Bonta noted that federal funds already don't cover abortions. He said the new provision was 'punishment for Planned Parenthood's constitutionally protected advocacy for abortion' and 'a direct attack on access to essential health care for millions who rely on Medicaid.' 'The Trump administration and Congress are actually gutting essential life-saving care, like cancer screenings and STI testing, simply because Planned Parenthood has spoken out in support of reproductive rights,' Bonta said. 'The hypocrisy is really hard to ignore. A party that claims to be defenders of free speech only seem to care about it when it aligns with their own agenda.' Bonta added: 'Rest assured, California will continue to lead as a reproductive freedom state, and will continue to defend healthcare as a human right.' In their lawsuit, the states argue that the measure is unlawfully ambiguous and violates the spending powers of Congress by singling out Planned Parenthood for negative treatment, and that it will harm people's health and increase the cost of Medicaid programs for states by more than $50 million over the next decade. In its lawsuit, Planned Parenthood also argued that the measure intentionally singled it and its affiliates out for punishment, in violation of their constitutional rights, including free speech. In granting Planned Parenthood's request for a preliminary injunction, U.S. District Judge Indira Talwani wrote Monday that she was 'not enjoining the federal government from regulating abortion and is not directing the federal government to fund elective abortions or any healthcare service not otherwise eligible for Medicaid coverage.' Talwani, an Obama appointee, wrote that she also was not requiring the federal government 'to spend money not already appropriated for Medicaid or any other funds.' Instead, Talwani wrote, her order blocks the Trump administration from 'targeting a specific group of entities — Planned Parenthood Federation members — for exclusion from reimbursements under the Medicaid program,' as they were likely to prove that 'such targeted exclusion violates the United States Constitution.' In a statement to The Times Tuesday, White House spokesman Harrison Fields said the 'Big, Beautiful Bill' was 'legally passed by both chambers of the Legislative Branch and signed into law by the Chief Executive,' and Talwani's order granting the injunction was 'not only absurd but illogical and incorrect.' 'It is orders like these that underscore the audacity of the lower courts as well as the chaos within the judicial branch. We look forward to ultimate victory on the issue,' Fields said. The White House did not immediately respond to a request for additional comment on the states' lawsuit. Jodi Hicks, president and CEO of Planned Parenthood Affiliates of California, joined Bonta during his news conference. She welcomed the states' lawsuit, saying 'an attack this severe requires a multi-pronged response with both short and long term strategies.' Hicks said it's particularly important that California is helping to fight back, given the huge stakes for the state. 'California is the most impacted state across the country because of the volume of patients that we have, but also because of the amount of Medicaid that our state takes,' she said. 'It speaks to our values. And this defund provision is certainly [an] attack on values — most heavily on California.' Bonta is leading the lawsuit along with the attorneys general of Connecticut and New York. Joining them are Pennsylvania Gov. Josh Shapiro and the attorneys general of Colorado, Delaware, Hawaii, Illinois, Maine, Maryland, Massachusetts, Michigan, Minnesota, Nevada, New Jersey, New Mexico, North Carolina, Oregon, Rhode Island, Vermont, Washington, Wisconsin and the District of Columbia. Bonta noted the lawsuit is the 36th his office has filed against the Trump administration in the last 27 weeks.
The Hill
an hour ago
- The Hill
FDA recommends concentrated Kratom be scheduled as illicit substance
The Trump administration is recommending that a compound called 7-OH be scheduled as an illicit drug, Food and Drug Administration Commissioner Marty Makary announced Tuesday. The compound is a concentrated by-product of the Kratom plant whose ground leaves are sold as a dietary supplement to boost energy or provide pain relief. FDA officials said the substance has a 'high risk of addiction' and abuse in concentrated form because of its ability to bind to opioid receptors in the brain. Makary said the agency is urging the Drug Enforcement Agency to classify 7-OH as a Schedule 1 substance, placing it on list of drugs that include heroin, lysergic acid diethylamide (LSD) and ecstasy. 'We have a history in public health of being asleep at the wheel,' Makary said. 'Public health is supposed to prevent disasters, not just clean them up after they've killed thousands and thousands of people.' The American Kratom Association (AKA), a trade group representing the industry, applauded the recommendation to classify 7-OH as a Schedule 1 substance. 'This bold step is a critical milestone in protecting public health and consumer safety from dangerous synthetic products that masquerade as natural kratom,' the AKA said in a statement. A spokesperson for the group said that the FDA's decision shines a light on a 'massive and growing' problem in the kratom marketplace. Earlier this month, the FDA sent warning letters to seven companies regarding allegations that they are illegally marketing 7-OH products as dietary supplements or as a product that can relieve pain or manage anxiety. Department of Health and Human Services officials said during a Tuesday press conference that they have seen a 'disturbing' rise in reports of poisonings and emergency room visits linked to products containing 7-OH which can be found in tablets, gummies, mixed drinks or shots. But officials did not point to data on the scale of the rise in adverse health events. These products are often sold online or in convenience stores, gas stations and vape shops, officials said, with no 'quality control, no dosage control and no warnings.' 'This is a recipe for a public health disaster,' said Jim O'Neil, deputy secretary at the Department of Health and Human Services. 'Young people, veterans and people who suffer from chronic pain or addiction are being misled into thinking that these are safe alternatives. They're not.' Kratom has gained popularity as an alternative pain reliever amid the country's opioid epidemic with some studies suggesting that up to 15 million Americans have use it to treat chronic pain or opioid withdrawal symptoms. In small doses, Kratom can act as a stimulant but can also cause an 'opioid-like' drowsiness and euphoria, experts say. Concentrated Kratom or highly potent Kratom products can cause harmful side effects like nausea, vomiting and even seizures. Tuesday's announcement is the Trump administration's effort to prevent another 'wave of the opioid epidemic' from blindsiding the country, Makaray said. 'There's a lot we don't know. This may be the calm before the storm,' he said. 'It may be the tip of the iceberg, but let's be aggressive and proactive.' The DEA previously announced it would schedule kratom compounds as controlled substances in 2016 but opted not to after receiving intense pushback. Makary stressed that the Trump administration is targeting synthetic, concentrated kratom when asked by a reporter if officials were prepared to deal with similar pushback again.
